Clinical Report: Impact of Statins and Antihypertensives on Obesity-Related Health Risks

Overview

A recent study indicates that adults aged 40 and older with obesity have blood pressure and cholesterol levels comparable to those with normal BMI, attributed to increased use of statins and antihypertensives.

Background

Obesity is a major public health concern, significantly increasing the risk of cardiovascular diseases and other chronic conditions. This study provides insights into how medical management may mitigate some cardiovascular risks associated with obesity.

Data Highlights

The study analyzed data from 1 million participants across seven countries from 1990 to 2024, revealing that blood pressure and cholesterol levels improved more significantly in adults with obesity compared to those with normal BMI.

Key Findings

• Adults aged 40-79 with obesity showed improved blood pressure and cholesterol levels over 25 years.
• 70-72% of older adults with obesity were on blood pressure medications or statins, compared to 40-48% of those with normal BMI.
• Young adults under 40 rarely received cholesterol or blood pressure medication, regardless of BMI.
• The study was observational and cannot establish causation.
• Changes in blood pressure and cholesterol were less pronounced in Taiwan and Thailand.

Clinical Implications

The findings indicate that increased use of antihypertensive and lipid-lowering medications may be contributing to improved cardiovascular risk profiles in older adults with obesity.

Conclusion

Further research is needed to evaluate the long-term outcomes of these changes.

Related Resources & Content

1. NCD Risk Factor Collaboration, The Lancet, 2024 -- Impact of Statins and Antihypertensives on Obesity-Related Health Risks
2. Obesity Surgery — Determinants of Statin Cessation After Metabolic and Bariatric Surgery: A Retrospective Study Utilizing Electronic Medical Records from 2012 to 2021
3. Journal of Medical Internet Research (JMIR) — Effects of Stand-Alone Digital Lifestyle Interventions on Weight-Related Outcomes in Adults With Overweight or Obesity: Systematic Review and Meta-Analysis of Randomized Controlled Trials
4. Endocrine Reviews — Obesity and Exercise: New Insights and Perspectives
5. Journal of General Internal Medicine — Reframing Statin Prescribing for Low-Risk Patients: A Two-Visit Approach
6. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
7. Overview of the 2025 Hypertension Guidelines
8. A Randomized Trial of Intensive versus Standard Blood-Pressure Control | New England Journal of Medicine
9. Effect of Statin Therapy on Clinical Outcomes in Patients With Cardiovascular Risks: A Systematic Review and Meta-Analysis - PMC
10. Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials | Diabetes Care | American Diabetes Association
11. expert reaction to study looking at blood pressure and cholesterol levels in adults with obesity versus in adults with normal BMI | Science Media Centre
12. 2026 Guideline on the Management of Dyslipidemia - Professional Heart Daily | American Heart Association